The largest analysis to date of patients taking GLP-1 receptor agonists (GLP-1RAs) has investigated their effects on nearly 175 diseases, and found that compared to three other classes of diabetes ...
It’s one thing for the scientific community to propose a fundamental change to the way obesity is defined and diagnosed. But ...
Immuron Ltd. has signed a new research collaboration agreement with Monash University to develop new therapeutic drug ...
Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator (CARB-X) will award a seed grant of $610,000 to Justus ...
Corneal neovascularization (CNV) occurs when abnormal blood vessels grow into the cornea in response to ischemic or hypoxic ...
In the final days of the Biden administration, the U.S. Department of Health and Human Services’ Centers for Medicare and ...
Boston Scientific Corp. reported positive data for two key atrial fibrillation therapies at AF Symposium 2025 on January 17.
Having 35 copies of the CAG triplet in the gene that causes Huntington’s disease is not a problem. Inheriting 40 could be a ...
As more Asia biotechs turn to regenerative medicine to address disorders without a cure, Medipost Inc. is continuing global ...
According to the World Health Organization (WHO), multidrug-resistant pathogens caused over 1.27 million deaths worldwide in ...
China is deepening its regulatory reforms of drugs and devices to foster a globally competitive innovation ecosystem to ...
With positive data in hand from its phase IIb trial testing immunotherapy candidate OST-HER2 in osteosarcoma, OS Therapies ...